nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—STAT3—embryo—polycystic ovary syndrome	0.0335	0.119	CbGeAlD
Niclosamide—STAT3—adrenal cortex—polycystic ovary syndrome	0.0274	0.0974	CbGeAlD
Niclosamide—STAT3—endometrium—polycystic ovary syndrome	0.0245	0.087	CbGeAlD
Niclosamide—CYP1A2—urine—polycystic ovary syndrome	0.0245	0.0869	CbGeAlD
Niclosamide—CYP2C9—urine—polycystic ovary syndrome	0.0232	0.0825	CbGeAlD
Niclosamide—STAT3—uterus—polycystic ovary syndrome	0.0226	0.0801	CbGeAlD
Niclosamide—STAT3—pituitary gland—polycystic ovary syndrome	0.0222	0.0787	CbGeAlD
Niclosamide—STAT3—adipose tissue—polycystic ovary syndrome	0.0221	0.0784	CbGeAlD
Niclosamide—STAT3—adrenal gland—polycystic ovary syndrome	0.0198	0.0703	CbGeAlD
Niclosamide—STAT3—female gonad—polycystic ovary syndrome	0.0185	0.0656	CbGeAlD
Niclosamide—STAT3—vagina—polycystic ovary syndrome	0.0183	0.0652	CbGeAlD
Niclosamide—STAT3—endocrine gland—polycystic ovary syndrome	0.0172	0.061	CbGeAlD
Niclosamide—Meclofenamic acid—AKR1C3—polycystic ovary syndrome	0.0131	1	CrCbGaD
Niclosamide—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00406	0.0144	CbGeAlD
Niclosamide—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00385	0.0137	CbGeAlD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.000618	0.000876	CbGpPWpGaD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000618	0.000876	CbGpPWpGaD
Niclosamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000603	0.000855	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000601	0.000852	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.000601	0.000852	CbGpPWpGaD
Niclosamide—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000601	0.000852	CbGpPWpGaD
Niclosamide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000595	0.000844	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000592	0.000839	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000592	0.000839	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—IL6—polycystic ovary syndrome	0.00058	0.000822	CbGpPWpGaD
Niclosamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000579	0.00082	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—AKT2—polycystic ovary syndrome	0.000575	0.000815	CbGpPWpGaD
Niclosamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000572	0.000811	CbGpPWpGaD
Niclosamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000569	0.000806	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL6—polycystic ovary syndrome	0.000567	0.000803	CbGpPWpGaD
Niclosamide—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000562	0.000797	CbGpPWpGaD
Niclosamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000561	0.000796	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000553	0.000784	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000547	0.000775	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000537	0.000762	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000522	0.000741	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FGF18—polycystic ovary syndrome	0.000512	0.000726	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000509	0.000722	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKR1C1—polycystic ovary syndrome	0.000509	0.000722	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.0005	0.000708	CbGpPWpGaD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000489	0.000693	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—IL6—polycystic ovary syndrome	0.000489	0.000693	CbGpPWpGaD
Niclosamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000486	0.000689	CbGpPWpGaD
Niclosamide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00048	0.00068	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000475	0.000674	CbGpPWpGaD
Niclosamide—STAT3—Disease—FGF18—polycystic ovary syndrome	0.000473	0.00067	CbGpPWpGaD
Niclosamide—STAT3—Disease—RBP4—polycystic ovary syndrome	0.000469	0.000664	CbGpPWpGaD
Niclosamide—STAT3—Immune System—GAB1—polycystic ovary syndrome	0.000467	0.000663	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000466	0.000661	CbGpPWpGaD
Niclosamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000461	0.000654	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00046	0.000652	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—IL6—polycystic ovary syndrome	0.000458	0.000649	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—LEP—polycystic ovary syndrome	0.00045	0.000638	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000442	0.000627	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000433	0.000614	CbGpPWpGaD
Niclosamide—STAT3—Disease—GAB1—polycystic ovary syndrome	0.000431	0.000612	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000427	0.000605	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CAMK2D—polycystic ovary syndrome	0.000425	0.000602	CbGpPWpGaD
Niclosamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000424	0.000601	CbGpPWpGaD
Niclosamide—STAT3—Disease—NAMPT—polycystic ovary syndrome	0.00042	0.000596	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TNRC6B—polycystic ovary syndrome	0.000418	0.000593	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000413	0.000585	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—IL6—polycystic ovary syndrome	0.000412	0.000584	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000407	0.000577	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000407	0.000577	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.000401	0.000568	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000398	0.000565	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000396	0.000561	CbGpPWpGaD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000394	0.000559	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000393	0.000557	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKR1C3—polycystic ovary syndrome	0.000392	0.000556	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—PPARG—polycystic ovary syndrome	0.000392	0.000555	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FST—polycystic ovary syndrome	0.000386	0.000547	CbGpPWpGaD
Niclosamide—STAT3—Disease—TNRC6B—polycystic ovary syndrome	0.000386	0.000547	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000385	0.000545	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—INS—polycystic ovary syndrome	0.000384	0.000545	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000384	0.000544	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—IL6—polycystic ovary syndrome	0.000382	0.000541	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000381	0.00054	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000379	0.000537	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000378	0.000536	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000377	0.000534	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—IL6—polycystic ovary syndrome	0.000373	0.000529	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—AKT2—polycystic ovary syndrome	0.000371	0.000527	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000368	0.000522	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ATF1—polycystic ovary syndrome	0.000367	0.00052	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—IL6—polycystic ovary syndrome	0.000367	0.00052	CbGpPWpGaD
Niclosamide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000362	0.000514	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000357	0.000505	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000353	0.0005	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000353	0.0005	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00035	0.000496	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00035	0.000496	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000348	0.000493	CbGpPWpGaD
Niclosamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000344	0.000487	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TAB1—polycystic ovary syndrome	0.000339	0.00048	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	0.000338	0.000479	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000337	0.000477	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PRL—polycystic ovary syndrome	0.000336	0.000476	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000331	0.000469	CbGpPWpGaD
Niclosamide—STAT3—Disease—TCF7L2—polycystic ovary syndrome	0.00033	0.000468	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000329	0.000466	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000328	0.000465	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000328	0.000465	CbGpPWpGaD
Niclosamide—STAT3—Disease—SLC2A4—polycystic ovary syndrome	0.000325	0.00046	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000324	0.000459	CbGpPWpGaD
Niclosamide—STAT3—Disease—PRL—polycystic ovary syndrome	0.00031	0.000439	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000306	0.000434	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000304	0.000431	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000302	0.000428	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.0003	0.000425	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000299	0.000424	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000299	0.000424	CbGpPWpGaD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000294	0.000416	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000293	0.000415	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000289	0.00041	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL18—polycystic ovary syndrome	0.000282	0.0004	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000282	0.000399	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000278	0.000394	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—IL6—polycystic ovary syndrome	0.000277	0.000393	CbGpPWpGaD
Niclosamide—STAT3—Immune System—NRG1—polycystic ovary syndrome	0.000276	0.000391	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000274	0.000389	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00027	0.000383	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000267	0.000379	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000265	0.000376	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL6—polycystic ovary syndrome	0.000264	0.000375	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—IL6—polycystic ovary syndrome	0.00026	0.000369	CbGpPWpGaD
Niclosamide—STAT3—Disease—NCOR1—polycystic ovary syndrome	0.00026	0.000368	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00026	0.000368	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000256	0.000363	CbGpPWpGaD
Niclosamide—STAT3—Disease—NRG1—polycystic ovary syndrome	0.000255	0.000361	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00025	0.000355	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000249	0.000353	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000249	0.000353	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000245	0.000347	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000243	0.000344	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000242	0.000342	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000237	0.000337	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000237	0.000336	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IRS2—polycystic ovary syndrome	0.000236	0.000335	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CRP—polycystic ovary syndrome	0.000236	0.000335	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000231	0.000328	CbGpPWpGaD
Niclosamide—STAT3—Disease—MTHFR—polycystic ovary syndrome	0.000229	0.000325	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000226	0.000321	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000225	0.00032	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000219	0.00031	CbGpPWpGaD
Niclosamide—STAT3—Disease—IRS2—polycystic ovary syndrome	0.000218	0.000309	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000217	0.000308	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000215	0.000305	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000209	0.000297	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IRS1—polycystic ovary syndrome	0.000206	0.000293	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000206	0.000293	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000206	0.000292	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000205	0.000291	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000201	0.000285	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000197	0.000279	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000197	0.000279	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000195	0.000276	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000193	0.000273	CbGpPWpGaD
Niclosamide—STAT3—Immune System—AKT2—polycystic ovary syndrome	0.000191	0.000271	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000191	0.000271	CbGpPWpGaD
Niclosamide—STAT3—Disease—IRS1—polycystic ovary syndrome	0.000191	0.00027	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000184	0.000261	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000183	0.00026	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000183	0.000259	CbGpPWpGaD
Niclosamide—STAT3—Disease—INS—polycystic ovary syndrome	0.000182	0.000259	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000182	0.000258	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000179	0.000254	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000178	0.000253	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKT2—polycystic ovary syndrome	0.000176	0.00025	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000176	0.000249	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000172	0.000243	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000168	0.000239	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000168	0.000239	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6—polycystic ovary syndrome	0.000168	0.000238	CbGpPWpGaD
Niclosamide—STAT3—Disease—SERPINE1—polycystic ovary syndrome	0.000168	0.000238	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000167	0.000237	CbGpPWpGaD
Niclosamide—STAT3—Immune System—BCL2—polycystic ovary syndrome	0.000167	0.000237	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000166	0.000236	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000159	0.000225	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000157	0.000222	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000156	0.000221	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000156	0.000221	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000156	0.000221	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000153	0.000217	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000153	0.000217	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00015	0.000212	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—LEP—polycystic ovary syndrome	0.00015	0.000212	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000147	0.000209	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000143	0.000202	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000136	0.000192	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000133	0.000189	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000133	0.000189	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000133	0.000189	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000131	0.000185	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—POMC—polycystic ovary syndrome	0.000129	0.000182	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000128	0.000181	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—INS—polycystic ovary syndrome	0.000128	0.000181	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000126	0.000179	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000124	0.000175	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000124	0.000175	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000124	0.000175	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000118	0.000167	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000117	0.000166	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000117	0.000165	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000112	0.000158	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000106	0.00015	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000105	0.000149	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000101	0.000143	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.0001	0.000142	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.97e-05	0.000141	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.92e-05	0.000141	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.4e-05	0.000133	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	9.15e-05	0.00013	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	8.99e-05	0.000127	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	8.94e-05	0.000127	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	8.66e-05	0.000123	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6—polycystic ovary syndrome	8.64e-05	0.000122	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	8.58e-05	0.000122	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.48e-05	0.00012	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.07e-05	0.000114	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.04e-05	0.000114	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6—polycystic ovary syndrome	7.97e-05	0.000113	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	7.97e-05	0.000113	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	7.82e-05	0.000111	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	7.72e-05	0.000109	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	7.64e-05	0.000108	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	7.44e-05	0.000106	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	7.4e-05	0.000105	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	7.15e-05	0.000101	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.11e-05	0.000101	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	7.06e-05	0.0001	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.01e-05	9.94e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	6.81e-05	9.66e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	6.67e-05	9.46e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	6.6e-05	9.36e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	6.57e-05	9.31e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	6.36e-05	9.02e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	6.11e-05	8.66e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.07e-05	8.61e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	6.03e-05	8.56e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.99e-05	8.49e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	5.7e-05	8.08e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—TH—polycystic ovary syndrome	5.68e-05	8.05e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	5.61e-05	7.95e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6—polycystic ovary syndrome	5.58e-05	7.92e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	5.53e-05	7.84e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	5.2e-05	7.37e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—TH—polycystic ovary syndrome	4.85e-05	6.88e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	4.72e-05	6.7e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	4.64e-05	6.58e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	4.44e-05	6.3e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	4.42e-05	6.26e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	4.19e-05	5.94e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	3.96e-05	5.62e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.9e-05	5.54e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	3.78e-05	5.35e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.58e-05	5.07e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	3.34e-05	4.73e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	3.17e-05	4.49e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	3.12e-05	4.43e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—INS—polycystic ovary syndrome	3.11e-05	4.4e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.71e-05	3.84e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.67e-05	3.78e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.65e-05	3.76e-05	CbGpPWpGaD
